Orgenesis Inc. announced that it has entered into a securities purchase agreement to issue 1,410,256 shares at a price of $0.78 per unit and warrants at a price of $1.1 million on November 8, 2023. The warrants will be exercisable immediately following the date of issuance and may be exercised for a period of five years from the initial exercisability date at an exercise price of $0.78 per share. The transaction is expected to close on November 9, 2023.